MCK - Pharma middlemen face govt. scrutiny over generic drug shortages
2024-02-14 10:24:17 ET
More on Cardinal Health, Cencora, etc.
- McKesson Corporation 2024 Q3 - Results - Earnings Call Presentation
- McKesson Corporation (MCK) Q3 2024 Earnings Call Transcript
- Cardinal Health, Inc. (CAH) Q2 2024 Earnings Call Transcript
- Argus upgrades Cardinal Health to buy, cites generics program
- Walgreens Boots Alliance sells Cencora shares for $992M